Octapharma AG:企業の戦略・SWOT・財務分析

◆英語タイトル:Octapharma AG - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY3792
◆発行会社(調査会社):MarketLine
◆発行日:2019年12月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥19,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥38,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥57,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Octapharma AG – Strategy, SWOT and Corporate Finance Report
Summary

Octapharma AG – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Octapharma AG (Octapharma or ‘the company’) is a human proteins manufacturer involved in the development and sale of human proteins for use in pharmaceuticals and medical treatments. Its product portfolio comprises of protein and other biopharmaceutical products derived from human plasma in three therapeutic areas: haematology, critical care, and immunotherapy. The company operates manufacturing facilities in Austria, France, Sweden, Germany, and Mexico. In addition, its research and development (R&D) facilities are also involved in research and development of human proteins for various therapeutic areas. The company operates through its subsidiaries in Europe, North and South Americas, Asia Pacific and the Middle East. The company is headquartered in Lachen, Switzerland.

Scope

- Detailed information on Octapharma AG required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Octapharma AG in the form of a SWOT analysis
- An in-depth view of the business model of Octapharma AG including a breakdown and examination of key business segments
- Intelligence on Octapharma AG’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Octapharma AG, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Octapharma AG and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Octapharma AG as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Octapharma AG’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Octapharma AG: Company Overview
Octapharma AG: Overview and Key Facts
Octapharma AG: Overview
Octapharma AG: Key Facts
Octapharma AG: Key Employees
Octapharma AG: Major Products and Services
Octapharma AG: Company History
Octapharma AG: Management Statement
Octapharma AG: Locations and Subsidiaries
Octapharma AG: Key Competitors
Octapharma AG: Company Analysis
Octapharma AG: Business Description
Octapharma AG: SWOT Analysis
Octapharma AG: SWOT Overview
Octapharma AG: Strengths
Octapharma AG: Weaknesses
Octapharma AG: Opportunities
Octapharma AG: Threats
Octapharma AG: Corporate Financial Deals Activity
Octapharma AG: Financial Deals Overview
Octapharma AG: Targets and Partners
Octapharma AG: Top Deals 2015 – 2019YTD*
Octapharma AG: Corporate Venturing
Octapharma AG: Partnership
Octapharma AG: Recent Developments
Octapharma AG: News and Events Summary
Octapharma AG: Contracts
Octapharma AG: Financial Performance
Octapharma AG: Regulatory and Legal Events
Octapharma AG: Research & Development
Octapharma AG: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Octapharma AG: Key Facts
Table 2: Octapharma AG: Key Employees
Table 3: Octapharma AG: Company History
Table 4: Octapharma AG: Locations and Subsidiaries
Table 5: Octapharma AG: Key Competitors
Table 6: Octapharma AG: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 7: Octapharma AG: Targets and Partners
Table 8: Octapharma AG: Top Deals 2015 - 2019YTD*
Table 9: Octapharma AG: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Table 10: Octapharma AG: Corporate Venturing by Geography (2015 - YTD*2019)
Table 11: Octapharma AG: Partnership Volume and Value Trend (2015 - YTD*2019)
Table 12: Octapharma AG: Partnership Trend by Deal Type (2015 - YTD*2019)
Table 13: Octapharma AG: News and Events Summary
Table 14: Octapharma AG: Contracts
Table 15: Octapharma AG: Financial Performance
Table 16: Octapharma AG: Regulatory and Legal Events
Table 17: Octapharma AG: Research & Development
Table 18: Octapharma AG: Strategy and Operations

★海外企業調査レポート[Octapharma AG:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Tata Power Co Ltd (TATAPOWER):企業の財務・戦略的SWOT分析
    The Tata Power Co Ltd (TATAPOWER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Kadmon Corp LLC-製薬・医療分野:企業M&A・提携分析
    Summary Kadmon Corp LLC (Kadmon) is a biopharmaceutical company that offers products and related services for the management and treatment of hepatitis C. The company also develops therapies for metabolic and serious diseases. Its products include ribavirin, USP Tablets, ribavirin capsules, phenterm …
  • Siam Food Products PCL:企業の戦略・SWOT・財務情報
    Siam Food Products PCL - Strategy, SWOT and Corporate Finance Report Summary Siam Food Products PCL - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Formosa Laboratories Inc (4746):製薬・医療:M&Aディール及び事業提携情報
    Summary Formosa Laboratories Inc (Formosa Laboratories) is a producer of active pharmaceutical ingredients and UV-filters. The company’s active pharmaceutical ingredients include cholesterol and phosphate binders, anticancers, CNS agents, immunomodulators, MRI enhancing agents, anti-inflammatory and …
  • CellaVision AB (CEVI)-医療機器分野:企業M&A・提携分析
    Summary CellaVision AB (CellaVision) is a medical technology company that provides digital solutions for medical microscopy in hematology. The company helps hematology laboratories improve and transform the analysis of blood and other body fluids. It has expertise in digital image analysis, automate …
  • Mercuria Energy Group Ltd:企業の戦略的SWOT分析
    Mercuria Energy Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Airborne Systems, Ltd.:企業の戦略・SWOT・財務情報
    Airborne Systems, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Airborne Systems, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Gas Malaysia Bhd (GASMSIA):企業の財務・戦略的SWOT分析
    Summary Gas Malaysia Bhd (Gas Malaysia) markets and distributes natural gas and liquefied petroleum gas (LPG). The company provides energy solutions which include power generation system with heat recovery such as power and combined heat; and alternative gas distribution such as virtual pipeline. It …
  • Zanders GmbH:企業の戦略的SWOT分析
    Zanders GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Innergex Renewable Energy Inc (INE):企業の財務・戦略的SWOT分析
    Innergex Renewable Energy Inc (INE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • ViaCyte Inc-製薬・医療分野:企業M&A・提携分析
    Summary ViaCyte Inc (ViaCyte), formerly Novocell, Inc. is a regenerative medicine company that focuses on the development of cell replacement therapies for the treatment of diabetes. The company’s pipeline product portfolio includes VC-01, which is being developed as a therapy for T1D patients who h …
  • Eris Lifesciences Ltd (ERIS):製薬・医療:M&Aディール及び事業提携情報
    Summary Eris Lifesciences Ltd (Eris Lifesciences) is a health care products and service provider. The company offers glimepride, telmisertan, methylcobalamin and combinations, vitamin d, rabeprazole, olmesartan, mecobalamin colecalciferol, teneligliptin, rosa canina extract, cilnidipine, atorvastati …
  • Atopix Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Atopix Therapeutics Ltd (Atopix) is a clinical stage biotechnology company that develops novel treatments for Th2-mediated eosinophilic asthma. The company’s product portfolio includes CRTH2 used in the treatment of atopic dermatitis. It also offers ATX2417 and OC459 used in treatment of ast …
  • KENKO Mayonnaise Co Ltd:企業の戦略・SWOT・財務分析
    KENKO Mayonnaise Co Ltd - Strategy, SWOT and Corporate Finance Report Summary KENKO Mayonnaise Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Data#3 Limited (DTL):企業の財務・戦略的SWOT分析
    Data#3 Limited (DTL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Ubisoft Entertainment S.A.:企業の戦略・SWOT・財務情報
    Ubisoft Entertainment S.A. - Strategy, SWOT and Corporate Finance Report Summary Ubisoft Entertainment S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Wolters Kluwer nv:企業の戦略・SWOT・財務分析
    Wolters Kluwer nv - Strategy, SWOT and Corporate Finance Report Summary Wolters Kluwer nv - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Life Healthcare Group Holdings Ltd (LHC):企業の財務・戦略的SWOT分析
    Life Healthcare Group Holdings Ltd (LHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Step Pharma SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Step Pharma SAS (Step Pharma) is a biotechnology company that strives to discover and develop proprietary small molecule medicines for the treatment of auto-immune diseases. The company is developing a new class of oral nucleotide synthesis inhibitors against cytidine triphosphate synthase 1 …
  • Demant AS (DEMANT):企業の財務・戦略的SWOT分析
    Demant AS (DEMANT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆